Mankind Pharma Limited (BOM:543904)
India
· Delayed Price · Currency is INR 2,269.95
+3.95 (0.17%)
At close: Apr 28, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 931.67 billion as of April 29, 2026. Its market cap has decreased by -7.88% in one year.
Market Cap
931.67B
Enterprise Value
982.80B
Revenue
139.14B
Ranking
n/a
PE Ratio
52.36
Stock Price
2,269.95
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 931.67B, an increase of 63.52%. That is a compound annual growth rate of 17.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 934.81B | 3.10% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1,049.73B |
| Dr. Reddy's Laboratories | 1,095.57B |
| Torrent Pharmaceuticals | 1,392.97B |
| Abbott India | 535.45B |
| GlaxoSmithKline Pharmaceuticals | 418.95B |
| J. B. Chemicals & Pharmaceuticals | 321.75B |
| AstraZeneca Pharma India | 212.54B |
| Granules India | 170.76B |